Study Decodes Deescalation: Impact of BRCA Pathogenic Variants on Neoadjuvant Treatment in Triple-Negative Breast Cancer Dr Pooja N.22 April 2025 8:45 PM ISTRecent investigation focuses on the effects of BRCA1 and BRCA2 tumor pathogenic variants (tPVs) within the parameters of two deescalated neoadjuvant...
Medical Bulletin 15/ November/ 2024 Dr. Bhumika Maikhuri15 Nov 2024 3:00 PM ISTHere are the top medical news for the day:Clinical Trial Finds Well Tolerated Vaccine for Aggressive Breast CancerA small clinical trial shows...
Clinical Trial Finds Well Tolerated Vaccine for Aggressive Breast Cancer Dr. Bhumika Maikhuri15 Nov 2024 8:00 AM ISTA small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to...
Medical Bulletin 17/ October/ 2024 Dr. Bhumika Maikhuri17 Oct 2024 3:00 PM ISTHere are the top medical news for the day:If You Are a Senior Who Lives Alone, be Careful of Your Dietary Vitamin IntakeOlder adults in the UK who are...
Study Identifies New Therapeutic Strategy for Most Aggressive and Deadly Type of Breast Cancer Dr. Bhumika Maikhuri17 Oct 2024 8:45 AM ISTTriple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham...
Medical Bulletin 07/ September/ 2024 Dr. Garima Soni7 Sept 2024 3:00 PM ISTHere are the top medical news for the dayStudy Links Nighttime Light Exposure to Increase Alzheimer's Risk in Adults Under 65In some places around the...
Research Finds Novel Mechanism That Predicts Severity Of Triple Negative Breast Cancer Dr. Garima Soni7 Sept 2024 8:15 AM ISTScientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer centre for the Mountain...
Justify Durvalumab dose: CDSCO Panel Tells AstraZeneca on Study of Dato-DXd and Durvalumab Dr. Divya Colin8 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the drug major AstraZeneca's Phase III clinical trial protocol of the anti-cancer drug of Dato-DXd and Durvualumab, the Subject...
CDSCO Panel Grants Novartis Protocol Amendment Proposal For Alpelisib Dr. Divya Colin7 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
AstraZeneca Gets CDSCO Panel Nod to Study anti-cancer drug Dato-DXd and Durvalumab Dr. Divya Colin5 Jan 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 6:50 PM ISTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Newer Vaccine may prevent Triple Negative Breast Cancer for the first time Dr Nisanth Puliyath12 Feb 2022 9:00 AM ISTThe Cleveland Clinic has begun clinical testing of a novel vaccine designed ultimately to prevent triple-negative breast cancer (TNBC) by priming...
